10-112166426-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001244949.2(GPAM):c.1197T>C(p.Asp399Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00372 in 1,602,358 control chromosomes in the GnomAD database, including 211 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.020 ( 111 hom., cov: 33)
Exomes 𝑓: 0.0020 ( 100 hom. )
Consequence
GPAM
NM_001244949.2 synonymous
NM_001244949.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.117
Genes affected
GPAM (HGNC:24865): (glycerol-3-phosphate acyltransferase, mitochondrial) This gene encodes a mitochondrial enzyme which prefers saturated fatty acids as its substrate for the synthesis of glycerolipids. This metabolic pathway's first step is catalyzed by the encoded enzyme. Two forms for this enzyme exist, one in the mitochondria and one in the endoplasmic reticulum. Two alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 10-112166426-A-G is Benign according to our data. Variant chr10-112166426-A-G is described in ClinVar as [Benign]. Clinvar id is 776543.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.117 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0676 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPAM | ENST00000348367.9 | c.1197T>C | p.Asp399Asp | synonymous_variant | Exon 12 of 22 | 1 | NM_001244949.2 | ENSP00000265276.4 | ||
GPAM | ENST00000369425.5 | c.1197T>C | p.Asp399Asp | synonymous_variant | Exon 12 of 19 | 1 | ENSP00000358433.1 |
Frequencies
GnomAD3 genomes AF: 0.0201 AC: 3063AN: 152144Hom.: 111 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
3063
AN:
152144
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00511 AC: 1286AN: 251418 AF XY: 0.00368 show subpopulations
GnomAD2 exomes
AF:
AC:
1286
AN:
251418
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00200 AC: 2902AN: 1450096Hom.: 100 Cov.: 28 AF XY: 0.00173 AC XY: 1247AN XY: 722354 show subpopulations
GnomAD4 exome
AF:
AC:
2902
AN:
1450096
Hom.:
Cov.:
28
AF XY:
AC XY:
1247
AN XY:
722354
Gnomad4 AFR exome
AF:
AC:
2375
AN:
33178
Gnomad4 AMR exome
AF:
AC:
150
AN:
44716
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26064
Gnomad4 EAS exome
AF:
AC:
0
AN:
39628
Gnomad4 SAS exome
AF:
AC:
13
AN:
86016
Gnomad4 FIN exome
AF:
AC:
0
AN:
53410
Gnomad4 NFE exome
AF:
AC:
110
AN:
1101360
Gnomad4 Remaining exome
AF:
AC:
238
AN:
59976
Heterozygous variant carriers
0
128
256
384
512
640
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0201 AC: 3062AN: 152262Hom.: 111 Cov.: 33 AF XY: 0.0198 AC XY: 1475AN XY: 74460 show subpopulations
GnomAD4 genome
AF:
AC:
3062
AN:
152262
Hom.:
Cov.:
33
AF XY:
AC XY:
1475
AN XY:
74460
Gnomad4 AFR
AF:
AC:
0.0696678
AN:
0.0696678
Gnomad4 AMR
AF:
AC:
0.00829957
AN:
0.00829957
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.000621891
AN:
0.000621891
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000161731
AN:
0.000161731
Gnomad4 OTH
AF:
AC:
0.012772
AN:
0.012772
Heterozygous variant carriers
0
149
297
446
594
743
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 23, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=94/6
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at